Tag: New York markets
No posts to display
Top News
Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability...
Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.
- Our Sponsors Ad -